Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.15
-0.80 (-8.04%)
At close: May 19, 2026, 4:00 PM EDT
9.35
+0.20 (2.19%)
After-hours: May 19, 2026, 7:55 PM EDT
Corbus Pharmaceuticals Holdings Employees
Corbus Pharmaceuticals Holdings had 36 employees as of December 31, 2025. The number of employees increased by 8 or 28.57% compared to the previous year.
Employees
36
Change (1Y)
8
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$2,348,000
Market Cap
162.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 36 | 8 | 28.57% |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Dec 31, 2023 | 19 | -14 | -42.42% |
| Dec 31, 2022 | 33 | -8 | -19.51% |
| Dec 31, 2021 | 41 | -35 | -46.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Heron Therapeutics | 128 |
| Nkarta | 108 |
| Tenaya Therapeutics | 70 |
| Precision BioSciences | 68 |
| Enlivex | 34 |
| Elicio Therapeutics | 33 |
| TuHURA Biosciences | 22 |
CRBP News
- 9 hours ago - Corbus Pharmaceuticals Holdings Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 5 days ago - Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors - GlobeNewsWire
- 5 days ago - Corbus Pharmaceuticals Holdings Slides: Corporate presentation - Filings
- 6 days ago - Corbus Pharmaceuticals Holdings Transcript: AGM 2026 - Transcripts
- 6 days ago - Corbus Pharmaceuticals price target lowered to $54 from $57 at Oppenheimer - TheFly
- 6 days ago - Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 days ago - Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies - TheFly
- 7 days ago - Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire